Related Experiment Videos
Three-dimensional conformal radiotherapy and dose escalation: where do we stand?
M J Zelefsky1, S A Leibel, G J Kutcher
1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Seminars in Radiation Oncology
|April 29, 1998
Summary
Three-dimensional conformal radiotherapy precisely delivers high radiation doses for prostate cancer, improving outcomes and tolerance. Further dose escalation with advanced techniques shows promise for better survival in high-risk patients.
Area of Science:
- Radiation Oncology
- Urologic Oncology
Background:
- Three-dimensional conformal radiotherapy (3D-CRT) is an established precise radiation delivery method.
- Institutions report excellent tolerance and improved outcomes with higher doses in localized prostate cancer.
Purpose of the Study:
- To evaluate the safety and efficacy of escalated radiation doses in prostate cancer treatment.
- To explore the correlation between radiation dose and patient outcomes.
Main Methods:
- Utilized 3D-CRT and intensity-modulated radiotherapy (IMRT) planning.
- Administered escalated radiation doses up to 86.4 Gy.
- Analyzed treatment technique and dose-volume histograms.
Main Results:
- Higher radiation doses demonstrated excellent tolerance and improved biochemical and local control.
- Dose escalation to 86.4 Gy was feasible while respecting normal tissue.
- A direct correlation exists between radiation dose and PSA relapse-free survival.
Conclusions:
- 3D-CRT and IMRT enable safe dose escalation for prostate cancer.
- Higher radiation doses correlate with improved outcomes, particularly in intermediate and high-risk patients.
- Further Phase I studies are needed to define maximal safe doses.